PRINCETON, N.J., Jan. 20, 2018 /PRNewswire/ — Taiho Oncology, Inc. and Servier today announced clinical data for LONSURF® (trifluridine and tipiracil) for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluropyrimidine-,…



Source link